PKM and lung cancer: Wang et al. (2021c) indicated that in lung cancer, hypoxia induces DDP-resistant cells to secrete abundant exosomal PKM2, promoting glycolysis and the production of reductive metabolites that may counteract the effects of DDP-induced ROS.